John H. Johnson
Chairman
Pharmaceutical Sciences
Strongbridge Biopharma
Sweden
Biography
John has served as chairman of our board of directors since March 2015. He is a recognized leader in the biopharmaceutical industry with more than 30 years of experience at leading global organizations, including Johnson & Johnson, Eli Lilly & Company, ImClone, and Pfizer, Inc. He currently serves as executive chairman of VirMedica, lead independent director of Sucampo Pharmaceuticals, Inc., and as a member of the board of directors of Cempra Pharmaceuticals, Inc., Histogenics Corporation, Portola Pharmaceuticals, Inc., and W20 Group. John previously served on the board of directors of Pharmaceutical Research and Manufacturers of America (PhRMA), the Health Section Governing Board of Biotechnology Industry Organizations (BIO), and BioNJ. John holds a BS from the East Stroudsburg University of Pennsylvania.
Research Interest
Pharmaceutical Technology, Biotechnology, Lipid technology etc.